Truist Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59M | Sell |
28,361
-17,325
| -38% | -$2.19M | 0.01% | 1005 |
|
|
2025
Q1 | $5.84M | Sell |
45,686
-7,201
| -14% | -$921K | 0.01% | 761 |
|
|
2024
Q4 | $6.99M | Buy |
52,887
+14,770
| +39% | +$1.95M | 0.01% | 687 |
|
|
2024
Q3 | $5.55M | Buy |
38,117
+2,758
| +8% | +$402K | 0.01% | 785 |
|
|
2024
Q2 | $4.85M | Sell |
35,359
-36,325
| -51% | -$4.99M | 0.01% | 868 |
|
|
2024
Q1 | $9.84M | Buy |
71,684
+44,682
| +165% | +$6.13M | 0.01% | 631 |
|
|
2023
Q4 | $3.67M | Sell |
27,002
-11,120
| -29% | -$1.51M | 0.01% | 981 |
|
|
2023
Q3 | $4.66M | Sell |
38,122
-27,146
| -42% | -$3.32M | 0.01% | 863 |
|
|
2023
Q2 | $8.29M | Sell |
65,268
-14,648
| -18% | -$1.86M | 0.01% | 648 |
|
|
2023
Q1 | $10.3M | Buy |
79,916
+5,709
| +8% | +$737K | 0.02% | 579 |
|
|
2022
Q4 | $9.74M | Buy |
74,207
+1,035
| +1% | +$136K | 0.02% | 578 |
|
|
2022
Q3 | $8.56M | Buy |
73,172
+12,890
| +21% | +$1.51M | 0.02% | 602 |
|
|
2022
Q2 | $7.09M | Sell |
60,282
-16,113
| -21% | -$1.9M | 0.01% | 690 |
|
|
2022
Q1 | $9.95M | Sell |
76,395
-24,503
| -24% | -$3.19M | 0.02% | 634 |
|
|
2021
Q4 | $15.4M | Buy |
100,898
+4,128
| +4% | +$630K | 0.02% | 506 |
|
|
2021
Q3 | $15.6M | Buy |
96,770
+2,494
| +3% | +$403K | 0.03% | 484 |
|
|
2021
Q2 | $15.4M | Buy |
94,276
+5,308
| +6% | +$869K | 0.03% | 499 |
|
|
2021
Q1 | $13.4M | Buy |
88,968
+197
| +0.2% | +$29.7K | 0.02% | 522 |
|
|
2020
Q4 | $13.4M | Buy |
88,771
+8,766
| +11% | +$1.33M | 0.03% | 516 |
|
|
2020
Q3 | $10.8M | Buy |
80,005
+8,004
| +11% | +$1.08M | 0.02% | 525 |
|
|
2020
Q2 | $9.84M | Buy |
72,001
+26,338
| +58% | +$3.6M | 0.02% | 532 |
|
|
2020
Q1 | $4.92M | Sell |
45,663
-23,994
| -34% | -$2.59M | 0.01% | 682 |
|
|
2019
Q4 | $8.39M | Buy |
+69,657
| New | +$8.39M | 0.02% | 619 |
|
|
2018
Q4 | – | Sell |
-2,571
| Closed | -$314K | – | 771 |
|
|
2018
Q3 | $314K | Buy |
2,571
+508
| +25% | +$62K | 0.01% | 673 |
|
|
2018
Q2 | $226K | Buy |
+2,063
| New | +$226K | ﹤0.01% | 716 |
|